Dosing & Administration
CYSTADROPS is the only viscous ophthalmic solution with practical, 4 times a day dosing for the depletion of corneal cystine crystals1
CYSTADROPS contains 0.37% of cysteamine (equivalent to 0.55% cysteamine hydrochloride). CYSTADROPS is formulated with carmellose sodium for greater viscosity.1
Cysteamine penetrates all layers of the cornea and converts cystine to cysteine and cysteine-cysteamine mixed disulfides which can then exit the lysosome. As a result, corneal cystine crystal accumulation is reduced over time with continued use.1,2
The most common adverse reactions (≥ 10%) reported during clinical trials were:
CYSTADROPS (cysteamine ophthalmic solution) 0.37% is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.
INDICATIONS AND IMPORTANT SAFETY INFORMATION